Early detection and prognosis of colon cancer metastasis are critical for patient survival, yet remain challenging due to the interaction of clinical, pathological, and genetic factors. We present a machine learning simulator for colon cancer liver metastasis risk prediction that estimates 3-year mortality by integrating genomic, mutational, and clinical data, providing individualized risk scores to support oncologists and researchers.
This tool bridges clinical and genomic data with practical applications, helping improve prognosis assessment in metastatic colon cancer.
Healthcare professionals can test it with Neural Designer.
Scope and limitations
This simulator is an educational and research demonstration of a statistical model. Its output depends on the variables, population, data quality and evaluation procedure used to create the model. A prediction for an individual does not establish a diagnosis, prognosis or treatment recommendation.
Do not use the result for clinical decisions or to replace qualified medical assessment. Before any real-world use, an independently governed clinical workflow would need representative validation data, documented inclusion criteria, calibration checks, uncertainty analysis, monitoring and approval under the applicable requirements.
For the modelling workflow behind this type of example, review testing analysis and the medical prognosis use case.